Evolvere BioSciences
PrivateLast Round
Accelerator
Aug 23, 2024
Total Funding Raised
$500,000
Company Overview
Evolvere BioSciences is a biotechnology company that develops a therapeutics platform to combat antimicrobial resistance by creating next-generation antibiotics using AI-powered computational models.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evolvere BioSciences Comparables
Compare Evolvere BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glox Therapeutics | 78% | |
| A-Alpha Bio | 66% | |
| Ailurus Biotechnology | 66% |
Evolvere BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 23, 2024 |
Evolvere BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
Evolvere BioSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evolvere BioSciences's valuation, stock price, and market status.
Is Evolvere BioSciences a public or private company?
Evolvere BioSciences is a private company.
What is the current stock price of Evolvere BioSciences?
Evolvere BioSciences is a private company with no public stock price. No recent secondary market data is available.
How much is Evolvere BioSciences worth (valuation)?
Valuation information for Evolvere BioSciences is not publicly available.
Can I buy Evolvere BioSciences stock?
Evolvere BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evolvere BioSciences's last funding round?
Evolvere BioSciences's most recent funding round was Seed on August 23, 2024.
Who are the main investors in Evolvere BioSciences?
Key investors in Evolvere BioSciences include Y Combinator.
Will Evolvere BioSciences IPO soon?
No public IPO plans have been announced for Evolvere BioSciences.
How can I track Evolvere BioSciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evolvere BioSciences's secondary market activity and sign up for updates.